GlaxoSmithKline plc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline plc with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 107.93 billion Danish Kroner [US$15.55 billion]
of which 79%
was Diabetes Care),
(34.86 billion Euro [US$37.36 billion]
of which 85%
was Pharmaceuticals), and
(£16.20 billion [US$20.10 billion]
of which 100%
During the year ended December of 2015, sales at
GlaxoSmithKline plc were £23.92 billion (US$29.68 billion).
increase of 4.0%
versus 2014, when the company's sales were £23.01 billion.
Despite this increase, sales are still
below the level achieved in 2013, when GlaxoSmithKline plc
reported sales of £26.51 billion.